Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3184
Selected: 0
NCT IDTitle
NCT00528034Lymphoscintigraphy in Patients With Vaginal Cancer
NCT01529593Temsirolimus in Combination With Metformin in Patients With Advanced Cancers
NCT00290433Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
NCT00054691ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin
NCT03592459Rectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced Cancer
NCT05017103Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study
NCT05054335Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients With Pelvic Sarcomas
NCT02577718Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution
NCT00512291Subcutaneous Olanzapine for Hyperactive or Mixed Delirium
NCT07009886Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy
NCT06408168Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)
NCT06066424Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
NCT01328860Autologous Stem Cells for Spinal Cord Injury (SCI) in Children
NCT00352846Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss
NCT01751425Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors
NCT04311723Ventilatory Strategy for the Prevention of Atelectasis During Bronchoscopy Under General Anesthesia, VESPA Trial
NCT02801578A Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)
NCT02861417Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
NCT02829840Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)
NCT06875882Evaluating Occupational Stress in Surgeons and Musicians: A Multi-modal Pilot Study Using Wearable EEG, Biomarker Analysis and Validated Questionnaires
NCT00041782Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
NCT05034562Gallium-68 PSMA-11 PET in Participants With Prostate Cancer
NCT00509860Irinotecan (Camptosar) in Patients With Advanced Sarcomas
NCT06285890Phase I Study of HC-7366 for Acute Myeloid Leukemia
NCT01891968Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation
NCT00968760CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies
NCT02932280Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
NCT01103388Rituximab Maintenance After Autologous Transplantation
NCT03010150Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
NCT01693523Minocycline Study in Pancreatic Cancer Patients
NCT00577980Testosterone in Castration-Resistant Prostate Cancer
NCT02166879Undetected Sleep Apnea in the Postanesthesia Acute Care Unit (PACU)
NCT00351988Effects of Cancer Symptoms on Caregivers
NCT01339052Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
NCT00102648Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide
NCT06285825A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia
NCT02420860Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
NCT03036904Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas
NCT03017833Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers
NCT03428126Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer
NCT03449108LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
NCT03008408A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma
NCT02530489Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer
NCT04021043BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers
NCT00823758Understanding Patient's Knowledge and Use of Acetaminophen
NCT00147225AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin
NCT02757391CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors
NCT02361320Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
NCT00069589Alopecia Areata Registry
NCT03707938Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer